Sign in

CIK 0002114044 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Hemab Therapeutics Holdings, Inc.

Sign in to watch
Ticker
COAG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
414241952
Phone
45 2138 7627
Business address
101 MAIN STREET, SUITE 1220, CAMBRIDGE, MA, 02142
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 4 Insider Changes in Ownership
  3. SCHEDULE 13D Stake Beneficial Ownership Report
  4. 8-K Event Executive or director change
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 8-K Event Bylaws or fiscal year change · Other events
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 424B4 Offering Prospectus
  14. EFFECT Other Notice of Effectiveness
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 2 of 3 · 53 filings